End-of-day quote
Other stock markets
|
||
- USD | - |
|
25/04 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M 2.04B |
---|---|---|---|---|---|
Net income 2022 | -9M -750M | Net income 2023 | -5M -417M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M 3.51B | Net cash position 2023 | 37.15M 3.1B | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/06/01 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/21/10 |
Sharon Perry
LAW | General Counsel | - | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/17/16 |
Robert Conway
CHM | Chairman | 70 | 03/13/03 |
Linda Grais
BRD | Director/Board Member | 68 | 01/07/01 |
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+17.99% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |